Abstract
Background Immunotherapy using immune checkpoint inhibitors (ICIs), such as antibody of programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) ha......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
